{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:21Z","timestamp":1790758581994,"version":"4.1.0"},"reference-count":144,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mesothelial cells (MCs) form the superficial anatomic layer of serosal membranes, including pleura, pericardium, peritoneum, and the tunica of the reproductive organs. MCs produce a protective, non-adhesive barrier against physical and biochemical damages. MCs express a wide range of phenotypic markers, including vimentin and cytokeratins. MCs play key roles in fluid transport and inflammation, as reflected by the modulation of biochemical markers such as transporters, adhesion molecules, cytokines, growth factors, reactive oxygen species and their scavengers. MCs synthesize extracellular matrix related molecules, and the surface of MC microvilli secretes a highly hydrophilic protective barrier, \u201cglycocalyx\u201d, consisting mainly of glycosaminoglycans. MCs maintain a balance between procoagulant and fibrinolytic activation by producing a whole range of regulators, can synthetize fibrin and therefore form adhesions. Synthesis and recognition of hyaluronan and sialic acids might be a new insight to explain immunoactive and immunoregulatory properties of MCs. Epithelial to mesenchymal transition of MCs may involve serosal repair and remodeling. MCs might also play a role in the development and remodeling of visceral adipose tissue. Taken together, MCs play important roles in health and disease in serosal cavities of the body. The mesothelium is not just a membrane and should be considered as an organ.<\/jats:p>","DOI":"10.1515\/pp-2016-0009","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T06:16:25Z","timestamp":1465452985000},"page":"79-89","source":"Crossref","is-referenced-by-count":55,"title":["Diverse properties of the mesothelial cells in health and disease"],"prefix":"10.1515","volume":"1","author":[{"given":"Kunio","family":"Kawanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"2025120909210679963_j_pp-2016-0009_ref_001_w2aab3b7b3b1b6b1ab1c12b1Aa","doi-asserted-by":"crossref","unstructured":"1. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002;7:171\u201391.","DOI":"10.1046\/j.1440-1843.2002.00404.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_002_w2aab3b7b3b1b6b1ab1c12b2Aa","doi-asserted-by":"crossref","unstructured":"2. Mutsaers SE. The mesothelial cell. Int J Biochem Cell Biol 2004;36:9\u201316.","DOI":"10.1016\/S1357-2725(03)00242-5"},{"key":"2025120909210679963_j_pp-2016-0009_ref_003_w2aab3b7b3b1b6b1ab1c12b3Aa","unstructured":"3. Michailova KN, Usunoff KG. Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology. Adv Anat Embryol Cell Biol 2006;183:i-vii, 1\u2013144."},{"key":"2025120909210679963_j_pp-2016-0009_ref_004_w2aab3b7b3b1b6b1ab1c12b4Aa","doi-asserted-by":"crossref","unstructured":"4. Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, et al. LRRN4 and UPK3B are markers of primary mesothelial cells. PLoS One 2011;6:e25391.","DOI":"10.1371\/journal.pone.0025391"},{"key":"2025120909210679963_j_pp-2016-0009_ref_005_w2aab3b7b3b1b6b1ab1c12b5Aa","doi-asserted-by":"crossref","unstructured":"5. Shelton EL, Galindo CL, Williams CH, Pfaltzgraff E, Hong CC, Bader DM. Autotaxin signaling governs phenotypic heterogeneity in visceral and parietal mesothelia. PLoS One 2013;8:e69712.","DOI":"10.1371\/journal.pone.0069712"},{"key":"2025120909210679963_j_pp-2016-0009_ref_006_w2aab3b7b3b1b6b1ab1c12b6Aa","doi-asserted-by":"crossref","unstructured":"6. Lua I, Li Y, Pappoe LS, Asahina K. Myofibroblastic conversion and regeneration of mesothelial cells in peritoneal and liver fibrosis. Am J Pathol 2015;185:3258\u201373.","DOI":"10.1016\/j.ajpath.2015.08.009"},{"key":"2025120909210679963_j_pp-2016-0009_ref_007_w2aab3b7b3b1b6b1ab1c12b7Aa","doi-asserted-by":"crossref","unstructured":"7. Ksi\u0105\u017cek K. Mesothelial cell: a multifaceted model of aging. Ageing Res Rev 2013;12:595\u2013604.","DOI":"10.1016\/j.arr.2013.01.008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_008_w2aab3b7b3b1b6b1ab1c12b8Aa","doi-asserted-by":"crossref","unstructured":"8. Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim CB, Pr\u00eale CM. Mesothelial cells in tissue repair and fibrosis. Front Pharmacol 2015;6:113.","DOI":"10.3389\/fphar.2015.00113"},{"key":"2025120909210679963_j_pp-2016-0009_ref_009_w2aab3b7b3b1b6b1ab1c12b9Aa","doi-asserted-by":"crossref","unstructured":"9. Chau YY, Bandiera R, Serrels A, Mart\u00ednez-Estrada OM, Qing W, Lee M, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol 2014;16:367\u201375.","DOI":"10.1038\/ncb2922"},{"key":"2025120909210679963_j_pp-2016-0009_ref_010_w2aab3b7b3b1b6b1ab1c12c10Aa","doi-asserted-by":"crossref","unstructured":"10. Liu Q, Huang X, Oh JH, Lin RZ, Duan S, Yu Y, et al. Epicardium-to-fat transition in injured heart. Cell Res 2014;24:1367\u20139.","DOI":"10.1038\/cr.2014.125"},{"key":"2025120909210679963_j_pp-2016-0009_ref_011_w2aab3b7b3b1b6b1ab1c12c11Aa","doi-asserted-by":"crossref","unstructured":"11. Wu YJ, Parker LM, Binder NE, Beckett MA, Sinard JH, Griffiths CT, et\u2009al. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 1982;31:693\u2013703.","DOI":"10.1016\/0092-8674(82)90324-5"},{"key":"2025120909210679963_j_pp-2016-0009_ref_012_w2aab3b7b3b1b6b1ab1c12c12Aa","doi-asserted-by":"crossref","unstructured":"12. Chung-Welch N, Patton WF, Yen-Patton GP, Hechtman HB, Shepro D. Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential. Differentiation 1989;42:44\u201353.","DOI":"10.1111\/j.1432-0436.1989.tb00606.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_013_w2aab3b7b3b1b6b1ab1c12c13Aa","doi-asserted-by":"crossref","unstructured":"13. Ito T, Yorioka N, Yamamoto M, Kataoka K, Yamakido M. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000;11:1969\u201379.","DOI":"10.1681\/ASN.V11111969"},{"key":"2025120909210679963_j_pp-2016-0009_ref_014_w2aab3b7b3b1b6b1ab1c12c14Aa","doi-asserted-by":"crossref","unstructured":"14. Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R, et al. Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer 2006;54:309\u201317.","DOI":"10.1016\/j.lungcan.2006.08.010"},{"key":"2025120909210679963_j_pp-2016-0009_ref_015_w2aab3b7b3b1b6b1ab1c12c15Aa","doi-asserted-by":"crossref","unstructured":"15. Zhang K, Zhang H, Zhou X, Tang WB, Xiao L, Liu YH, et al. miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells. J Biomed Biotechnol 2012;2012:673096.","DOI":"10.1155\/2012\/673096"},{"key":"2025120909210679963_j_pp-2016-0009_ref_016_w2aab3b7b3b1b6b1ab1c12c16Aa","unstructured":"16. Ye Z, Li M, Mei Z, Zhen G, Zhang P. The effects and mechanisms of interleukin-22 and interferon-\u03b3 on epithelial-mesenchymal transition of pleural mesothelial cells. Zhonghua Jie He He Hu Xi Za Zhi 2015;38:501\u20136."},{"key":"2025120909210679963_j_pp-2016-0009_ref_017_w2aab3b7b3b1b6b1ab1c12c17Aa","doi-asserted-by":"crossref","unstructured":"17. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, et\u2009al. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405\u201312.","DOI":"10.1097\/00000478-200111000-00008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_018_w2aab3b7b3b1b6b1ab1c12c18Aa","doi-asserted-by":"crossref","unstructured":"18. Ando T, Jordan P, Wang Y, Jennings MH, Harper MH, Houghton J, et al. Homogeneity of mesothelial cells with lymphatic endothelium: expression of lymphatic endothelial markers by mesothelial cells. Lymphat Res Biol 2005;3:117\u201325.","DOI":"10.1089\/lrb.2005.3.117"},{"key":"2025120909210679963_j_pp-2016-0009_ref_019_w2aab3b7b3b1b6b1ab1c12c19Aa","doi-asserted-by":"crossref","unstructured":"19. Patel P, Sekiguchi Y, Oh KH, Patterson SE, Kolb MR, Margetts PJ. Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. Kidney Int 2010;77:319\u201328.","DOI":"10.1038\/ki.2009.436"},{"key":"2025120909210679963_j_pp-2016-0009_ref_020_w2aab3b7b3b1b6b1ab1c12c20Aa","doi-asserted-by":"crossref","unstructured":"20. Lachaud CC, Soria F, Escacena N, Quesada-Hern\u00e1ndez E, Hmadcha A, Ali\u00f3 J, et al. Mesothelial cells: a cellular surrogate for tissue engineering of corneal endothelium. Invest Ophthalmol Vis Sci 2014;55:5967\u201378.","DOI":"10.1167\/iovs.14-14706"},{"key":"2025120909210679963_j_pp-2016-0009_ref_021_w2aab3b7b3b1b6b1ab1c12c21Aa","doi-asserted-by":"crossref","unstructured":"21. Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, et al. Wilms\u2019 tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. FASEB J 2014;28:1122\u201331.","DOI":"10.1096\/fj.13-236828"},{"key":"2025120909210679963_j_pp-2016-0009_ref_022_w2aab3b7b3b1b6b1ab1c12c22Aa","doi-asserted-by":"crossref","unstructured":"22. Duim SN, Kurakula K, Goumans MJ, Kruithof BP. Cardiac endothelial cells express Wilms\u2019 tumor-1: Wt1 expression in the developing, adult and infarcted heart. J Mol Cell Cardiol 2015 Apr;81:127\u201335.","DOI":"10.1016\/j.yjmcc.2015.02.007"},{"key":"2025120909210679963_j_pp-2016-0009_ref_023_w2aab3b7b3b1b6b1ab1c12c23Aa","doi-asserted-by":"crossref","unstructured":"23. Ma J, Tang WK, Esser L, Pastan I, Xia D. Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights. J Biol Chem 2012;287:33123\u201331.","DOI":"10.1074\/jbc.M112.381756"},{"key":"2025120909210679963_j_pp-2016-0009_ref_024_w2aab3b7b3b1b6b1ab1c12c24Aa","doi-asserted-by":"crossref","unstructured":"24. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;166:913\u201321.","DOI":"10.1016\/S0002-9440(10)62311-5"},{"key":"2025120909210679963_j_pp-2016-0009_ref_025_w2aab3b7b3b1b6b1ab1c12c25Aa","doi-asserted-by":"crossref","unstructured":"25. Asahina K, Tsai SY, Li P, Ishii M, Maxson Jr RE, Sucov HM, et al. Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 2009;49:998\u20131011.","DOI":"10.1002\/hep.22721"},{"key":"2025120909210679963_j_pp-2016-0009_ref_026_w2aab3b7b3b1b6b1ab1c12c26Aa","doi-asserted-by":"crossref","unstructured":"26. Yuan ML, Tong ZH, Jin XG, Zhang JC, Wang XJ, Ma WL, et al. Regulation of CD4(+) T cells by pleural mesothelial cells via adhesion molecule-dependent mechanisms in tuberculous pleurisy. PLoS One 2013;8:e74624.","DOI":"10.1371\/journal.pone.0074624"},{"key":"2025120909210679963_j_pp-2016-0009_ref_027_w2aab3b7b3b1b6b1ab1c12c27Aa","doi-asserted-by":"crossref","unstructured":"27. Kim YD, Jun YJ, Kim J, Kim CK. Effects of human adipose-derived stem cells on the regeneration of damaged visceral pleural mesothelial cells: a morphological study in a rabbit model. Interact Cardiovasc Thorac Surg 2014;19:363\u20137.","DOI":"10.1093\/icvts\/ivu124"},{"key":"2025120909210679963_j_pp-2016-0009_ref_028_w2aab3b7b3b1b6b1ab1c12c28Aa","doi-asserted-by":"crossref","unstructured":"28. do Amaral RJ, Benac P, Andrade LR, Farina M, Bernardazzi C, Arcanjo KD, et al. Peritoneal submesothelial stromal cells support hematopoiesis and differentiate into osteogenic and adipogenic cell lineages. Cells Tissues Organs 2014;20:118\u201331.","DOI":"10.1159\/000377624"},{"key":"2025120909210679963_j_pp-2016-0009_ref_029_w2aab3b7b3b1b6b1ab1c12c29Aa","doi-asserted-by":"crossref","unstructured":"29. Basok A, Shnaider A, Man L, Chaimovitz C, Douvdevani A. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 2001;12:695\u2013702.","DOI":"10.1681\/ASN.V124695"},{"key":"2025120909210679963_j_pp-2016-0009_ref_030_w2aab3b7b3b1b6b1ab1c12c30Aa","doi-asserted-by":"crossref","unstructured":"30. Gardner MJ, Jones LM, Catterall JB, Turner GA. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 1995;91:229\u201334.","DOI":"10.1016\/0304-3835(95)03743-G"},{"key":"2025120909210679963_j_pp-2016-0009_ref_031_w2aab3b7b3b1b6b1ab1c12c31Aa","doi-asserted-by":"crossref","unstructured":"31. Faull RJ, Stanley JM, Fraser S, Power DA, Leavesley DI. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int 2001;59:614\u201324.","DOI":"10.1046\/j.1523-1755.2001.059002614.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_032_w2aab3b7b3b1b6b1ab1c12c32Aa","doi-asserted-by":"crossref","unstructured":"32. Jonji\u0107 N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992;176:1165\u201374.","DOI":"10.1084\/jem.176.4.1165"},{"key":"2025120909210679963_j_pp-2016-0009_ref_033_w2aab3b7b3b1b6b1ab1c12c33Aa","doi-asserted-by":"crossref","unstructured":"33. Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ. Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 2000;82:1233\u20138.","DOI":"10.1054\/bjoc.1999.1068"},{"key":"2025120909210679963_j_pp-2016-0009_ref_034_w2aab3b7b3b1b6b1ab1c12c34Aa","doi-asserted-by":"crossref","unstructured":"34. Klein CL, Bittinger F, Skarke CC, Wagner M, K\u00f6hler H, Walgenbach S, et al. Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology 1995;63:204\u201312.","DOI":"10.1159\/000163953"},{"key":"2025120909210679963_j_pp-2016-0009_ref_035_w2aab3b7b3b1b6b1ab1c12c35Aa","doi-asserted-by":"crossref","unstructured":"35. Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 1989 Aug;15:940\u20136.","DOI":"10.1182\/blood.V74.3.940.940"},{"key":"2025120909210679963_j_pp-2016-0009_ref_036_w2aab3b7b3b1b6b1ab1c12c36Aa","doi-asserted-by":"crossref","unstructured":"36. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, et al. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992;1:2835\u201342.","DOI":"10.1182\/blood.V80.11.2835.bloodjournal80112835"},{"key":"2025120909210679963_j_pp-2016-0009_ref_037_w2aab3b7b3b1b6b1ab1c12c37Aa","unstructured":"37. Topley N, Brown Z, J\u00f6rres A, Westwick J, Davies M, Coles GA, et\u2009al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 1993;142:1876\u201386."},{"key":"2025120909210679963_j_pp-2016-0009_ref_038_w2aab3b7b3b1b6b1ab1c12c38Aa","doi-asserted-by":"crossref","unstructured":"38. Boylan AM, R\u00fcegg C, Kim KJ, H\u00e9bert CA, Hoeffel JM, Pytela R, et al. Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 1992;89:1257\u201367.","DOI":"10.1172\/JCI115710"},{"key":"2025120909210679963_j_pp-2016-0009_ref_039_w2aab3b7b3b1b6b1ab1c12c39Aa","doi-asserted-by":"crossref","unstructured":"39. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hart M, et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 1993;168:1202\u201310.","DOI":"10.1093\/infdis\/168.5.1202"},{"key":"2025120909210679963_j_pp-2016-0009_ref_040_w2aab3b7b3b1b6b1ab1c12c40Aa","doi-asserted-by":"crossref","unstructured":"40. Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998;54:2170\u201383.","DOI":"10.1046\/j.1523-1755.1998.00174.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_041_w2aab3b7b3b1b6b1ab1c12c41Aa","doi-asserted-by":"crossref","unstructured":"41. Gary Lee YC, Melkerneker D, Thompson PJ, Light RW, Lane KB. Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med 2002;165:88\u201394.","DOI":"10.1164\/ajrccm.165.1.2104006"},{"key":"2025120909210679963_j_pp-2016-0009_ref_042_w2aab3b7b3b1b6b1ab1c12c42Aa","doi-asserted-by":"crossref","unstructured":"42. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002;61:570\u20138.","DOI":"10.1046\/j.1523-1755.2002.00143.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_043_w2aab3b7b3b1b6b1ab1c12c43Aa","doi-asserted-by":"crossref","unstructured":"43. Acencio MM, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, et al. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung 2007;185:343\u20138.","DOI":"10.1007\/s00408-007-9041-y"},{"key":"2025120909210679963_j_pp-2016-0009_ref_044_w2aab3b7b3b1b6b1ab1c12c44Aa","doi-asserted-by":"crossref","unstructured":"44. Shukla A, MacPherson MB, Hillegass J, Ramos-Nino ME, Alexeeva V, Vacek PM, et al. Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity. Am J Respir Cell Mol Biol 2009;41:114\u201323.","DOI":"10.1165\/rcmb.2008-0146OC"},{"key":"2025120909210679963_j_pp-2016-0009_ref_045_w2aab3b7b3b1b6b1ab1c12c45Aa","doi-asserted-by":"crossref","unstructured":"45. Hong FY, Bao JF, Hao J, Yu Q, Liu J. Methylglyoxal and advanced glycation end-products promote cytokines expression in peritoneal mesothelial cells via MAPK signaling. Am J Med Sci 2015;349:105\u20139.","DOI":"10.1097\/MAJ.0000000000000394"},{"key":"2025120909210679963_j_pp-2016-0009_ref_046_w2aab3b7b3b1b6b1ab1c12c46Aa","doi-asserted-by":"crossref","unstructured":"46. Morishita Y, Ookawara S, Hirahara I, Muto S, Nagata D. HIF-1\u03b1 mediates Hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells. Ren Fail 2016;38:282\u20139.","DOI":"10.3109\/0886022X.2015.1127741"},{"key":"2025120909210679963_j_pp-2016-0009_ref_047_w2aab3b7b3b1b6b1ab1c12c47Aa","doi-asserted-by":"crossref","unstructured":"47. Cronauer MV, Stadlmann S, Klocker H, Abendstein B, Eder IE, Rogatsch H, et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol 1999;155:1977\u201384.","DOI":"10.1016\/S0002-9440(10)65516-2"},{"key":"2025120909210679963_j_pp-2016-0009_ref_048_w2aab3b7b3b1b6b1ab1c12c48Aa","unstructured":"48. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996;148:1679\u201388."},{"key":"2025120909210679963_j_pp-2016-0009_ref_049_w2aab3b7b3b1b6b1ab1c12c49Aa","unstructured":"49. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, et\u2009al. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997;150:981\u201391."},{"key":"2025120909210679963_j_pp-2016-0009_ref_050_w2aab3b7b3b1b6b1ab1c12c50Aa","doi-asserted-by":"crossref","unstructured":"50. Abendstein B, Stadlmann S, Knabbe C, Buck M, M\u00fcller-Holzner E, Zeimet AG, et al. Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 2000;12:1115\u201319.","DOI":"10.1006\/cyto.1999.0632"},{"key":"2025120909210679963_j_pp-2016-0009_ref_051_w2aab3b7b3b1b6b1ab1c12c51Aa","doi-asserted-by":"crossref","unstructured":"51. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol 2000;43:285\u201391.","DOI":"10.1111\/j.8755-8920.2000.430507.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_052_w2aab3b7b3b1b6b1ab1c12c52Aa","doi-asserted-by":"crossref","unstructured":"52. Versnel MA, Hagemeijer A, Bouts MJ, van der Kwast TH, Hoogsteden HC. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene 1988;2:601\u20135.","DOI":"10.1016\/0165-4608(89)90660-2"},{"key":"2025120909210679963_j_pp-2016-0009_ref_053_w2aab3b7b3b1b6b1ab1c12c53Aa","doi-asserted-by":"crossref","unstructured":"53. Patel P, West-Mays J, Kolb M, Rodrigues JC, Hoff CM, Margetts PJ. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 2010;29:97\u2013106.","DOI":"10.1016\/j.matbio.2009.10.004"},{"key":"2025120909210679963_j_pp-2016-0009_ref_054_w2aab3b7b3b1b6b1ab1c12c54Aa","doi-asserted-by":"crossref","unstructured":"54. Kimura I, Sakamoto Y, Shibasaki M, Kobayashi Y, Matsuo H. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. Eur Respir J 2000;15:170\u20136.","DOI":"10.1183\/09031936.00.15117000"},{"key":"2025120909210679963_j_pp-2016-0009_ref_055_w2aab3b7b3b1b6b1ab1c12c55Aa","unstructured":"55. Lee TC, Zhang Y, Aston C, Hintz R, Jagirdar J, Perle MA, et\u2009al. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res 1993;53:2858\u201364."},{"key":"2025120909210679963_j_pp-2016-0009_ref_056_w2aab3b7b3b1b6b1ab1c12c56Aa","doi-asserted-by":"crossref","unstructured":"56. Adamson IY, Bakowska J. KGF and HGF are growth factors for mesothelial cells in pleural lavage fluid after intratracheal asbestos. Exp Lung Res 2001;27:605\u201316.","DOI":"10.1080\/019021401753181854"},{"key":"2025120909210679963_j_pp-2016-0009_ref_057_w2aab3b7b3b1b6b1ab1c12c57Aa","doi-asserted-by":"crossref","unstructured":"57. Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, Hoidal JR, et\u2009al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 1993;91:1792\u20139.","DOI":"10.1172\/JCI116390"},{"key":"2025120909210679963_j_pp-2016-0009_ref_058_w2aab3b7b3b1b6b1ab1c12c58Aa","doi-asserted-by":"crossref","unstructured":"58. Rougier JP, Moullier P, Piedagnel R, Ronco PM. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 1997;51:337\u201347.","DOI":"10.1038\/ki.1997.42"},{"key":"2025120909210679963_j_pp-2016-0009_ref_059_w2aab3b7b3b1b6b1ab1c12c59Aa","doi-asserted-by":"crossref","unstructured":"59. Ma C, Tarnuzzer RW, Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen 1999;7:477\u201385.","DOI":"10.1046\/j.1524-475X.1999.00477.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_060_w2aab3b7b3b1b6b1ab1c12c60Aa","doi-asserted-by":"crossref","unstructured":"60. Choe N, Tanaka S, Kagan E. Asbestos fibers and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells. Am J Respir Cell Mol Biol 1998;19:226\u201336.","DOI":"10.1165\/ajrcmb.19.2.3111"},{"key":"2025120909210679963_j_pp-2016-0009_ref_061_w2aab3b7b3b1b6b1ab1c12c61Aa","doi-asserted-by":"crossref","unstructured":"61. Owens MW, Milligan SA, Grisham MB. Nitric oxide synthesis by rat pleural mesothelial cells: induction by growth factors and lipopolysaccharide. Exp Lung Res 1995;21:731\u201342.","DOI":"10.3109\/01902149509050839"},{"key":"2025120909210679963_j_pp-2016-0009_ref_062_w2aab3b7b3b1b6b1ab1c12c62Aa","doi-asserted-by":"crossref","unstructured":"62. Hillegass JM, Shukla A, MacPherson MB, Lathrop SA, Alexeeva V, Perkins TN, et al. Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells. Part Fibre Toxicol 2010;7:26.","DOI":"10.1186\/1743-8977-7-26"},{"key":"2025120909210679963_j_pp-2016-0009_ref_063_w2aab3b7b3b1b6b1ab1c12c63Aa","doi-asserted-by":"crossref","unstructured":"63. Thompson JK, Westbom CM, MacPherson MB, Mossman BT, Heintz NH, Spiess P, et\u2009al. Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. Part Fibre Toxicol 2014;11:24.","DOI":"10.1186\/1743-8977-11-24"},{"key":"2025120909210679963_j_pp-2016-0009_ref_064_w2aab3b7b3b1b6b1ab1c12c64Aa","doi-asserted-by":"crossref","unstructured":"64. Yu M, Chen R, Jia Z, Chen J, Lou J, Tang S, et\u2009al. MWCNTs induce ROS generation, ERK phosphorylation, and SOD-2 expression in human mesothelial cells. Int J Toxicol 2016;35:17\u201326.","DOI":"10.1177\/1091581815591223"},{"key":"2025120909210679963_j_pp-2016-0009_ref_065_w2aab3b7b3b1b6b1ab1c12c65Aa","doi-asserted-by":"crossref","unstructured":"65. Harvey W, Amlot PL. Collagen production by human mesothelial cells in vitro. J Pathol 1983;139:337\u201347.","DOI":"10.1002\/path.1711390309"},{"key":"2025120909210679963_j_pp-2016-0009_ref_066_w2aab3b7b3b1b6b1ab1c12c66Aa","doi-asserted-by":"crossref","unstructured":"66. Rennard SI, Jaurand MC, Bignon J, Kawanami O, Ferrans VJ, Davidson J, et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 1984;130:267\u201374.","DOI":"10.1164\/arrd.1984.130.2.267"},{"key":"2025120909210679963_j_pp-2016-0009_ref_067_w2aab3b7b3b1b6b1ab1c12c67Aa","doi-asserted-by":"crossref","unstructured":"67. Kuwahara M, Kuwahara M, Bijwaard KE, Gersten DM, Diglio CA, Kagan E. Mesothelial cells produce a chemoattractant for lung fibroblasts: role of fibronectin. Am J Respir Cell Mol Biol 1991 Sep;5:256\u201364.","DOI":"10.1165\/ajrcmb\/5.3.256"},{"key":"2025120909210679963_j_pp-2016-0009_ref_068_w2aab3b7b3b1b6b1ab1c12c68Aa","doi-asserted-by":"crossref","unstructured":"68. Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 1993;265:L382\u20138.","DOI":"10.1152\/ajplung.1993.265.4.L382"},{"key":"2025120909210679963_j_pp-2016-0009_ref_069_w2aab3b7b3b1b6b1ab1c12c69Aa","doi-asserted-by":"crossref","unstructured":"69. Owens MW, Milligan SA. Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor. Inflammation 1994;18:77\u201387.","DOI":"10.1007\/BF01534600"},{"key":"2025120909210679963_j_pp-2016-0009_ref_070_w2aab3b7b3b1b6b1ab1c12c70Aa","doi-asserted-by":"crossref","unstructured":"70. Kuwahara M, Kuwahara M, Verma K, Ando T, Hemenway DR, Kagan E. Asbestos exposure stimulates pleural mesothelial cells to secrete the fibroblast chemoattractant, fibronectin. Am J Respir Cell Mol Biol 1994;10:167\u201376.","DOI":"10.1165\/ajrcmb.10.2.8110473"},{"key":"2025120909210679963_j_pp-2016-0009_ref_071_w2aab3b7b3b1b6b1ab1c12c71Aa","doi-asserted-by":"crossref","unstructured":"71. Owens MW, Milligan SA, Grisham MB. Inhibition of pleural mesothelial cell collagen synthesis by nitric oxide. Free Radic Biol Med 1996;21:601\u20137.","DOI":"10.1016\/0891-5849(96)00159-1"},{"key":"2025120909210679963_j_pp-2016-0009_ref_072_w2aab3b7b3b1b6b1ab1c12c72Aa","doi-asserted-by":"crossref","unstructured":"72. Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen 1999;7:504\u201310.","DOI":"10.1046\/j.1524-475X.1999.00504.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_073_w2aab3b7b3b1b6b1ab1c12c73Aa","doi-asserted-by":"crossref","unstructured":"73. Yang WS, Kim BS, Lee SK, Park JS, Kim SB. Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int 1999;19:211\u201320.","DOI":"10.1177\/089686089901900306"},{"key":"2025120909210679963_j_pp-2016-0009_ref_074_w2aab3b7b3b1b6b1ab1c12c74Aa","doi-asserted-by":"crossref","unstructured":"74. Zhang H, Liu FY, Liu YH, Peng YM, Liao Q, Zhang K. Effect of TGF-\u03b21. Stimulation on the smad signal transduction pathway of human peritoneal mesothelial cells. Int J Biomed Sci 2005;1:8\u201315.","DOI":"10.59566\/IJBS.2005.1008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_075_w2aab3b7b3b1b6b1ab1c12c75Aa","doi-asserted-by":"crossref","unstructured":"75. Xiao L, Sun L, Liu FY, Peng YM, Duan SB. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells. Ther Apher Dial 2010;14:27\u201334.","DOI":"10.1111\/j.1744-9987.2009.00701.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_076_w2aab3b7b3b1b6b1ab1c12c76Aa","doi-asserted-by":"crossref","unstructured":"76. Noh H, Ha H, Yu MR, Kim YO, Kim JH, Lee HB. Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 2005;25:38\u201347.","DOI":"10.1177\/089686080502500110"},{"key":"2025120909210679963_j_pp-2016-0009_ref_077_w2aab3b7b3b1b6b1ab1c12c77Aa","doi-asserted-by":"crossref","unstructured":"77. Tong M, Wang Y, Wang Y, Chen H, Wang C, Yang L, et al. Genistein attenuates advanced glycation end product-induced expression of fibronectin and connective tissue growth factor. Am J Nephrol 2012;36:34\u201340.","DOI":"10.1159\/000339168"},{"key":"2025120909210679963_j_pp-2016-0009_ref_078_w2aab3b7b3b1b6b1ab1c12c78Aa","doi-asserted-by":"crossref","unstructured":"78. Baumann MH, Strange C, Sahn SA, Kinasewitz GT. Pleural macrophages differentially alter pleural mesothelial cell glycosaminoglycan production. Exp Lung Res 1996;22:101\u201311.","DOI":"10.3109\/01902149609074020"},{"key":"2025120909210679963_j_pp-2016-0009_ref_079_w2aab3b7b3b1b6b1ab1c12c79Aa","doi-asserted-by":"crossref","unstructured":"79. Yung S, Chan TM. Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan. J Biomed Biotechnol 2011;2011:180594.","DOI":"10.1155\/2011\/180594"},{"key":"2025120909210679963_j_pp-2016-0009_ref_080_w2aab3b7b3b1b6b1ab1c12c80Aa","doi-asserted-by":"crossref","unstructured":"80. Kenny HA, Chiang CY, White EA, Schryver EM, Habis M. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest 2014;124:4614\u201328.","DOI":"10.1172\/JCI74778"},{"key":"2025120909210679963_j_pp-2016-0009_ref_081_w2aab3b7b3b1b6b1ab1c12c81Aa","doi-asserted-by":"crossref","unstructured":"81. Kumar A, Koenig KB, Johnson AR, Idell S. Expression and assembly of procoagulant complexes by human pleural mesothelial cells. Thromb Haemost 1994;71:587\u201392.","DOI":"10.1055\/s-0038-1642487"},{"key":"2025120909210679963_j_pp-2016-0009_ref_082_w2aab3b7b3b1b6b1ab1c12c82Aa","doi-asserted-by":"crossref","unstructured":"82. Bottles KD, Laszik Z, Morrissey JH, Kinasewitz GT. Tissue factor expression inmesothelial cells: induction both in vivo and in vitro. Am J Respir Cell Mol Biol 1997;17:164\u201372.","DOI":"10.1165\/ajrcmb.17.2.2438"},{"key":"2025120909210679963_j_pp-2016-0009_ref_083_w2aab3b7b3b1b6b1ab1c12c83Aa","doi-asserted-by":"crossref","unstructured":"83. Dobbie JW, Jasani MK. Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD. Perit Dial Int 1997;17:121\u20134.","DOI":"10.1177\/089686089701700204"},{"key":"2025120909210679963_j_pp-2016-0009_ref_084_w2aab3b7b3b1b6b1ab1c12c84Aa","doi-asserted-by":"crossref","unstructured":"84. Bajaj MS, Pendurthi U, Koenig K, Pueblitz S, Idell S. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells. Eur Respir J 2000;15:1069\u201378.","DOI":"10.1034\/j.1399-3003.2000.01515.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_085_w2aab3b7b3b1b6b1ab1c12c85Aa","doi-asserted-by":"crossref","unstructured":"85. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990;75:1490\u20137.","DOI":"10.1182\/blood.V75.7.1490.bloodjournal7571490"},{"key":"2025120909210679963_j_pp-2016-0009_ref_086_w2aab3b7b3b1b6b1ab1c12c86Aa","doi-asserted-by":"crossref","unstructured":"86. Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992;7:414\u201326.","DOI":"10.1165\/ajrcmb\/7.4.414"},{"key":"2025120909210679963_j_pp-2016-0009_ref_087_w2aab3b7b3b1b6b1ab1c12c87Aa","doi-asserted-by":"crossref","unstructured":"87. Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995;10:677\u201383.","DOI":"10.1093\/ndt\/10.5.677"},{"key":"2025120909210679963_j_pp-2016-0009_ref_088_w2aab3b7b3b1b6b1ab1c12c88Aa","doi-asserted-by":"crossref","unstructured":"88. Sitter T, Toet K, Quax P, Kooistra T. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Kidney Int 1999;55:120\u20139.","DOI":"10.1046\/j.1523-1755.1999.00244.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_089_w2aab3b7b3b1b6b1ab1c12c89Aa","doi-asserted-by":"crossref","unstructured":"89. Rougier JP, Guia S, Hag\u00e8ge J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int 1998;54:87\u201398.","DOI":"10.1046\/j.1523-1755.1998.00955.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_090_w2aab3b7b3b1b6b1ab1c12c90Aa","doi-asserted-by":"crossref","unstructured":"90. Falk P, Ma C, Chegini N, Holmdahl L. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scand J Clin Lab Invest 2000;60:439\u201347.","DOI":"10.1080\/003655100448419"},{"key":"2025120909210679963_j_pp-2016-0009_ref_091_w2aab3b7b3b1b6b1ab1c12c91Aa","doi-asserted-by":"crossref","unstructured":"91. Perkins RC, Broaddus VC, Shetty S, Hamilton S, Idell S. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Am J Respir Cell Mol Biol 1999;21:637\u201346.","DOI":"10.1165\/ajrcmb.21.5.3225"},{"key":"2025120909210679963_j_pp-2016-0009_ref_092_w2aab3b7b3b1b6b1ab1c12c92Aa","doi-asserted-by":"crossref","unstructured":"92. Ivarsson ML, Holmdahl L, Falk P, M\u00f6lne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998;58:195\u2013203.","DOI":"10.1080\/00365519850186580"},{"key":"2025120909210679963_j_pp-2016-0009_ref_093_w2aab3b7b3b1b6b1ab1c12c93Aa","doi-asserted-by":"crossref","unstructured":"93. Maciver AH, McCall M, James Shapiro AM. Intra-abdominal adhesions: cellular mechanisms and strategies for prevention. Int J Surg 2011;9:589\u201394.","DOI":"10.1016\/j.ijsu.2011.08.008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_094_w2aab3b7b3b1b6b1ab1c12c94Aa","doi-asserted-by":"crossref","unstructured":"94. Naor D. Editorial: Interaction between hyaluronic acid and its receptors (CD44, RHAMM) regulates the activity of inflammation and cancer. Front Immunol 2016;7:39.","DOI":"10.3389\/fimmu.2016.00039"},{"key":"2025120909210679963_j_pp-2016-0009_ref_095_w2aab3b7b3b1b6b1ab1c12c95Aa","doi-asserted-by":"crossref","unstructured":"95. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011;91:221\u201364.","DOI":"10.1152\/physrev.00052.2009"},{"key":"2025120909210679963_j_pp-2016-0009_ref_096_w2aab3b7b3b1b6b1ab1c12c96Aa","doi-asserted-by":"crossref","unstructured":"96. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000;58:1953\u201362.","DOI":"10.1046\/j.1523-1755.2000.00367.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_097_w2aab3b7b3b1b6b1ab1c12c97Aa","doi-asserted-by":"crossref","unstructured":"97. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998;93:139\u201348.","DOI":"10.1046\/j.1365-2567.1998.00431.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_098_w2aab3b7b3b1b6b1ab1c12c98Aa","doi-asserted-by":"crossref","unstructured":"98. Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn J Cancer Res 1996;87:1235\u201344.","DOI":"10.1111\/j.1349-7006.1996.tb03138.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_099_w2aab3b7b3b1b6b1ab1c12c99Aa","doi-asserted-by":"crossref","unstructured":"99. Ohta S, Hiramoto S, Amano Y, Sato M, Suzuki Y, Shinohara M, et\u2009al. Production of Cisplatin-Incorporating Hyaluronan Nanogels via Chelating Ligand-Metal Coordination. Bioconjug Chem 2016;27:504\u20138.","DOI":"10.1021\/acs.bioconjchem.5b00674"},{"key":"2025120909210679963_j_pp-2016-0009_ref_100_w2aab3b7b3b1b6b1ab1c12d100Aa","unstructured":"100. Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993;53:3830\u20138."},{"key":"2025120909210679963_j_pp-2016-0009_ref_101_w2aab3b7b3b1b6b1ab1c12d101Aa","doi-asserted-by":"crossref","unstructured":"101. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672\u20135.","DOI":"10.1126\/science.278.5338.672"},{"key":"2025120909210679963_j_pp-2016-0009_ref_102_w2aab3b7b3b1b6b1ab1c12d102Aa","doi-asserted-by":"crossref","unstructured":"102. Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood 2006;107:619\u201327.","DOI":"10.1182\/blood-2005-06-2277"},{"key":"2025120909210679963_j_pp-2016-0009_ref_103_w2aab3b7b3b1b6b1ab1c12d103Aa","doi-asserted-by":"crossref","unstructured":"103. Lai KN, Szeto CC, Lai KB, Lam CW, Chan DT, Leung JC. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD. Am J Kidney Dis 1999;33:318\u201324.","DOI":"10.1016\/S0272-6386(99)70307-0"},{"key":"2025120909210679963_j_pp-2016-0009_ref_104_w2aab3b7b3b1b6b1ab1c12d104Aa","doi-asserted-by":"crossref","unstructured":"104. Al\u00ec G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, et al. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia. J Thorac Oncol 2013;8:1389\u201395.","DOI":"10.1097\/JTO.0b013e3182a59f45"},{"key":"2025120909210679963_j_pp-2016-0009_ref_105_w2aab3b7b3b1b6b1ab1c12d105Aa","doi-asserted-by":"crossref","unstructured":"105. Koistinen V, Jokela T, Oikari S, K\u00e4rn\u00e4 R, Tammi M, Rilla K. Hyaluronan-positive plasma membrane protrusions exist on mesothelial cells in vivo. Histochem Cell Biol 2016;145:531\u201344.","DOI":"10.1007\/s00418-016-1405-z"},{"key":"2025120909210679963_j_pp-2016-0009_ref_106_w2aab3b7b3b1b6b1ab1c12d106Aa","doi-asserted-by":"crossref","unstructured":"106. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995;128:687\u201398.","DOI":"10.1083\/jcb.128.4.687"},{"key":"2025120909210679963_j_pp-2016-0009_ref_107_w2aab3b7b3b1b6b1ab1c12d107Aa","doi-asserted-by":"crossref","unstructured":"107. Murai T. Lipid raft-mediated regulation of hyaluronan-CD44 interactions inflammation and cancer. Front Immunol 2015;6:420.","DOI":"10.3389\/fimmu.2015.00420"},{"key":"2025120909210679963_j_pp-2016-0009_ref_108_w2aab3b7b3b1b6b1ab1c12d108Aa","doi-asserted-by":"crossref","unstructured":"108. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 2007;446:1023\u20139.","DOI":"10.1038\/nature05816"},{"key":"2025120909210679963_j_pp-2016-0009_ref_109_w2aab3b7b3b1b6b1ab1c12d109Aa","doi-asserted-by":"crossref","unstructured":"109. Chou HH, Hayakawa T, Diaz S, Krings M, Indriati E. Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci USA 2002;99:11736\u201341.","DOI":"10.1073\/pnas.182257399"},{"key":"2025120909210679963_j_pp-2016-0009_ref_110_w2aab3b7b3b1b6b1ab1c12d110Aa","doi-asserted-by":"crossref","unstructured":"110. Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 2003;100:12045\u201350.","DOI":"10.1073\/pnas.2131556100"},{"key":"2025120909210679963_j_pp-2016-0009_ref_111_w2aab3b7b3b1b6b1ab1c12d111Aa","doi-asserted-by":"crossref","unstructured":"111. Angata T, Nycholat CM, Macauley MS. Therapeutic targeting of siglecs using antibody- and glycan-based approaches. Trends Pharmacol Sci 2015;36:645\u201360.","DOI":"10.1016\/j.tips.2015.06.008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_112_w2aab3b7b3b1b6b1ab1c12d112Aa","doi-asserted-by":"crossref","unstructured":"112. Tzanakakis GN, Syrokou A, Kanakis I, Karamanos NK. Determination and distribution of N-acetyl- and N-glycolylneuraminic acids in culture media and cell-associated glycoconjugates from human malignant mesothelioma and adenocarcinoma cells. Biomed Chromatogr 2006;20:434\u20139.","DOI":"10.1002\/bmc.573"},{"key":"2025120909210679963_j_pp-2016-0009_ref_113_w2aab3b7b3b1b6b1ab1c12d113Aa","doi-asserted-by":"crossref","unstructured":"113. Tatsuta T, Hosono M, Takahashi K, Omoto T, Kariya Y, Sugawara S, et al. Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL. Int J Oncol 2014;44:377\u201384.","DOI":"10.3892\/ijo.2013.2192"},{"key":"2025120909210679963_j_pp-2016-0009_ref_114_w2aab3b7b3b1b6b1ab1c12d114Aa","doi-asserted-by":"crossref","unstructured":"114. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001;21:560\u20137.","DOI":"10.1177\/089686080102100605"},{"key":"2025120909210679963_j_pp-2016-0009_ref_115_w2aab3b7b3b1b6b1ab1c12d115Aa","doi-asserted-by":"crossref","unstructured":"115. Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol Cancer 2010;9:118.","DOI":"10.1186\/1476-4598-9-118"},{"key":"2025120909210679963_j_pp-2016-0009_ref_116_w2aab3b7b3b1b6b1ab1c12d116Aa","doi-asserted-by":"crossref","unstructured":"116. Tyler C, Kapur A, Felder M, Belisle JA, Trautman C, Gubbels JA, et al. The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia. Am J Reprod Immunol 2012;68:28\u201337.","DOI":"10.1111\/j.1600-0897.2012.01113.x"},{"key":"2025120909210679963_j_pp-2016-0009_ref_117_w2aab3b7b3b1b6b1ab1c12d117Aa","doi-asserted-by":"crossref","unstructured":"117. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, et\u2009al. Nod1\/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007;179:514\u201321.","DOI":"10.4049\/jimmunol.179.1.514"},{"key":"2025120909210679963_j_pp-2016-0009_ref_118_w2aab3b7b3b1b6b1ab1c12d118Aa","unstructured":"118. Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, et\u2009al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 2004;15:1289\u201399."},{"key":"2025120909210679963_j_pp-2016-0009_ref_119_w2aab3b7b3b1b6b1ab1c12d119Aa","doi-asserted-by":"crossref","unstructured":"119. Hegmans JP, Hemmes A, Hammad H, Boon L, Hoogsteden HC, Lambrecht BN. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J 2006;27:1086\u201395.","DOI":"10.1183\/09031936.06.00135305"},{"key":"2025120909210679963_j_pp-2016-0009_ref_120_w2aab3b7b3b1b6b1ab1c12d120Aa","doi-asserted-by":"crossref","unstructured":"120. Lin CY, Kift-Morgan A, Moser B, Topley N, Eberl M. Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol Dial Transplant 2013;28:1743\u201350.","DOI":"10.1093\/ndt\/gfs612"},{"key":"2025120909210679963_j_pp-2016-0009_ref_121_w2aab3b7b3b1b6b1ab1c12d121Aa","doi-asserted-by":"crossref","unstructured":"121. Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Yamashita H, Seto Y, et al. CD90(+)CD45(\u2212) intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I. Cell Immunol 2014;288:8\u201314.","DOI":"10.1016\/j.cellimm.2014.01.008"},{"key":"2025120909210679963_j_pp-2016-0009_ref_122_w2aab3b7b3b1b6b1ab1c12d122Aa","doi-asserted-by":"crossref","unstructured":"122. L\u00f3pez-Cabrera M. Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis. Adv Med 2014;2014:473134.","DOI":"10.1155\/2014\/473134"},{"key":"2025120909210679963_j_pp-2016-0009_ref_123_w2aab3b7b3b1b6b1ab1c12d123Aa","doi-asserted-by":"crossref","unstructured":"123. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000;35:644\u201352.","DOI":"10.1016\/S0272-6386(00)70011-4"},{"key":"2025120909210679963_j_pp-2016-0009_ref_124_w2aab3b7b3b1b6b1ab1c12d124Aa","doi-asserted-by":"crossref","unstructured":"124. Gangji AS, Brimble KS, Margetts PJ. Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif 2009;28:354\u20138.","DOI":"10.1159\/000232937"},{"key":"2025120909210679963_j_pp-2016-0009_ref_125_w2aab3b7b3b1b6b1ab1c12d125Aa","doi-asserted-by":"crossref","unstructured":"125. Yao Q, Pawlaczyk K, Ayala ER, Styszynski A, Breborowicz A, Heimburger O, et al. The role of the TGF\/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol 2008;109:e71\u20138.","DOI":"10.1159\/000142529"},{"key":"2025120909210679963_j_pp-2016-0009_ref_126_w2aab3b7b3b1b6b1ab1c12d126Aa","doi-asserted-by":"crossref","unstructured":"126. Aroeira LS, Aguilera A, S\u00e1nchez-Tomero JA, Bajo MA, del Peso G, Jim\u00e9nez-Heffernan JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007;18:2004\u201313.","DOI":"10.1681\/ASN.2006111292"},{"key":"2025120909210679963_j_pp-2016-0009_ref_127_w2aab3b7b3b1b6b1ab1c12d127Aa","doi-asserted-by":"crossref","unstructured":"127. Gonz\u00e1lez-Mateo GT, Aroeira LS, L\u00f3pez-Cabrera M, Ruiz-Ortega M, Ortiz A, Selgas R. Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option? Nephrol Dial Transplant 2012 Feb;27:478\u201381.","DOI":"10.1093\/ndt\/gfr543"},{"key":"2025120909210679963_j_pp-2016-0009_ref_128_w2aab3b7b3b1b6b1ab1c12d128Aa","doi-asserted-by":"crossref","unstructured":"128. Strippoli R, Benedicto I, Perez Lozano ML, Pellinen T, Sandoval P, Lopez-Cabrera M, et al. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLoS One 2012;7:e31492.","DOI":"10.1371\/journal.pone.0031492"},{"key":"2025120909210679963_j_pp-2016-0009_ref_129_w2aab3b7b3b1b6b1ab1c12d129Aa","doi-asserted-by":"crossref","unstructured":"129. Strippoli R, Benedicto I, P\u00e9rez Lozano ML, Cerezo A, L\u00f3pez-Cabrera M, del Pozo MA. Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK\/NF-kappaB\/Snail1 pathway. Dis Model Mech 2008;1:264\u201374.","DOI":"10.1242\/dmm.001321"},{"key":"2025120909210679963_j_pp-2016-0009_ref_130_w2aab3b7b3b1b6b1ab1c12d130Aa","doi-asserted-by":"crossref","unstructured":"130. Zhu F, Li T, Qiu F, Fan J, Zhou Q, Ding X, et\u2009al. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol 2010;176:650\u20139.","DOI":"10.2353\/ajpath.2010.090447"},{"key":"2025120909210679963_j_pp-2016-0009_ref_131_w2aab3b7b3b1b6b1ab1c12d131Aa","doi-asserted-by":"crossref","unstructured":"131. Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, et\u2009al. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006;21:2943\u20137.","DOI":"10.1093\/ndt\/gfl355"},{"key":"2025120909210679963_j_pp-2016-0009_ref_132_w2aab3b7b3b1b6b1ab1c12d132Aa","doi-asserted-by":"crossref","unstructured":"132. Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, Park SH, et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 2009;20:567\u201381.","DOI":"10.1681\/ASN.2008040424"},{"key":"2025120909210679963_j_pp-2016-0009_ref_133_w2aab3b7b3b1b6b1ab1c12d133Aa","doi-asserted-by":"crossref","unstructured":"133. Loureiro J, Schilte M, Aguilera A, Albar-Vizca\u00edno P, Ram\u00edrez-Huesca M, P\u00e9rez-Lozano ML, et al. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant 2010;25:1098\u2013108.","DOI":"10.1093\/ndt\/gfp618"},{"key":"2025120909210679963_j_pp-2016-0009_ref_134_w2aab3b7b3b1b6b1ab1c12d134Aa","doi-asserted-by":"crossref","unstructured":"134. Wang X, Li X, Ye L, Chen W, Yu X. Smad7 inhibits TGF-\u03b21-induced MCP-1 upregulation through a MAPK\/p38 pathway in rat peritoneal mesothelial cells. Int Urol Nephrol 2013;45:899\u2013907.","DOI":"10.1007\/s11255-012-0350-6"},{"key":"2025120909210679963_j_pp-2016-0009_ref_135_w2aab3b7b3b1b6b1ab1c12d135Aa","doi-asserted-by":"crossref","unstructured":"135. Guo H, Leung JC, Lam MF, Chan LY, Tsang AW, Lan HY, et\u2009al. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol 2007;18:2689\u2013703.","DOI":"10.1681\/ASN.2007010121"},{"key":"2025120909210679963_j_pp-2016-0009_ref_136_w2aab3b7b3b1b6b1ab1c12d136Aa","doi-asserted-by":"crossref","unstructured":"136. Nie J, Dou X, Hao W, Wang X, Peng W, Jia Z, et al. Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int 2007;72:1336\u201344.","DOI":"10.1038\/sj.ki.5002533"},{"key":"2025120909210679963_j_pp-2016-0009_ref_137_w2aab3b7b3b1b6b1ab1c12d137Aa","doi-asserted-by":"crossref","unstructured":"137. Strippoli R, Benedicto I, Foronda M, Perez-Lozano ML, S\u00e1nchez-Perales S, L\u00f3pez-Cabrera M, et al. p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition. J Cell Sci 2010;123:4321\u201331.","DOI":"10.1242\/jcs.071647"},{"key":"2025120909210679963_j_pp-2016-0009_ref_138_w2aab3b7b3b1b6b1ab1c12d138Aa","doi-asserted-by":"crossref","unstructured":"138. Chen YT, Chang YT, Pan SY, Chou YH, Chang FC, Yeh PY, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 2014;25:2847\u201358.","DOI":"10.1681\/ASN.2013101079"},{"key":"2025120909210679963_j_pp-2016-0009_ref_139_w2aab3b7b3b1b6b1ab1c12d139Aa","doi-asserted-by":"crossref","unstructured":"139. Liu Y, Dong Z, Liu H, Zhu J, Liu F, Chen G. Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander? Perit Dial Int 2015;35:14\u201325.","DOI":"10.3747\/pdi.2014.00188"},{"key":"2025120909210679963_j_pp-2016-0009_ref_140_w2aab3b7b3b1b6b1ab1c12d140Aa","doi-asserted-by":"crossref","unstructured":"140. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761\u2013811.","DOI":"10.1152\/physrev.1994.74.4.761"},{"key":"2025120909210679963_j_pp-2016-0009_ref_141_w2aab3b7b3b1b6b1ab1c12d141Aa","doi-asserted-by":"crossref","unstructured":"141. Gaggini M, Saponaro C, Gastaldelli A. Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases. Horm Mol Biol Clin Investig 2015;22:7\u201318.","DOI":"10.1515\/hmbci-2015-0006"},{"key":"2025120909210679963_j_pp-2016-0009_ref_142_w2aab3b7b3b1b6b1ab1c12d142Aa","doi-asserted-by":"crossref","unstructured":"142. Darimont C, Avanti O, Blancher F, Wagniere S, Mansourian R, Zbinden I. Contribution of mesothelial cells in the expression of inflammatory-related fetal actors in omental adipose tissue of obese subjects. Int J Obes (Lond) 2008;32:112\u201320.","DOI":"10.1038\/sj.ijo.0803688"},{"key":"2025120909210679963_j_pp-2016-0009_ref_143_w2aab3b7b3b1b6b1ab1c12d143Aa","doi-asserted-by":"crossref","unstructured":"143. Zhang H, Pu W, Liu Q, He L, Huang X, Tian X, et al. Endocardium contributes to cardiac fat. Circ Res 2016;118:254\u201365.","DOI":"10.1161\/CIRCRESAHA.115.307202"},{"key":"2025120909210679963_j_pp-2016-0009_ref_144_w2aab3b7b3b1b6b1ab1c12d144Aa","doi-asserted-by":"crossref","unstructured":"144. Lansley SM, Searles RG, Hoi A, Thomas C, Moneta H, HerrickSE, et al. Mesothelial cell differentiation into osteoblast- and adipocyte-like cells. J Cell Mol Med 2011;15:2095\u2013105.","DOI":"10.1111\/j.1582-4934.2010.01212.x"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/1\/2\/article-p79.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0009\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0009\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:45:50Z","timestamp":1765277150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2016-0009\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":144,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,9]]},"published-print":{"date-parts":[[2016,6,1]]}},"alternative-id":["10.1515\/pp-2016-0009"],"URL":"https:\/\/doi.org\/10.1515\/pp-2016-0009","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}